AN OPEN-LABEL PHASE 2 STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF RILZABRUTINIB IN ADULT PARTICIPANTS WITH GRAVES' DISEASE

Registry ID

PDY18663

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE2

Study type

INTERVENTIONAL

Sponsor

SANOFI-AVENTIS CANADA INC

Start date

2025-05-24

Last update

2025-04-30

Conditions

• GRAVE'S DISEASE

Related clinical trials

• A PHASE 3, RANDOMIZED, DOUBLE-MASKED, PLACEBO-CONTROLLED, MULTICENTER STUDY EVALUATING THE EFFICACY AND SAFETY OF EFGARTIGIMOD PH20 SC PFS IN ADULT PARTICIPANTS WITH GRAVES’ DISEASE INADEQUATELY CONTROLLED WITH ANTITHYROID DRUGS

View on source registry